INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 104 filers reported holding INSMED INC in Q1 2017. The put-call ratio across all filers is 4.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,990,473 | +22.2% | 197,643 | +2.1% | 0.01% | +20.0% |
Q2 2023 | $4,084,158 | +127529.9% | 193,562 | +3.1% | 0.01% | +25.0% |
Q1 2023 | $3,200 | -12.2% | 187,672 | +2.9% | 0.00% | -20.0% |
Q4 2022 | $3,644 | -99.9% | 182,365 | +13.9% | 0.01% | 0.0% |
Q3 2022 | $3,449,000 | +19.6% | 160,111 | +9.5% | 0.01% | +25.0% |
Q2 2022 | $2,884,000 | -4.0% | 146,239 | +14.4% | 0.00% | 0.0% |
Q1 2022 | $3,003,000 | -9.7% | 127,777 | +4.7% | 0.00% | 0.0% |
Q4 2021 | $3,325,000 | -1.4% | 122,054 | -0.3% | 0.00% | -20.0% |
Q3 2021 | $3,373,000 | +2.3% | 122,462 | +5.7% | 0.01% | +25.0% |
Q2 2021 | $3,297,000 | -19.5% | 115,861 | -3.7% | 0.00% | -33.3% |
Q1 2021 | $4,098,000 | -8.6% | 120,330 | -10.7% | 0.01% | 0.0% |
Q4 2020 | $4,486,000 | +6.9% | 134,766 | +3.3% | 0.01% | -14.3% |
Q3 2020 | $4,195,000 | -4.9% | 130,517 | -18.5% | 0.01% | 0.0% |
Q2 2020 | $4,411,000 | +115.1% | 160,162 | +25.2% | 0.01% | +75.0% |
Q1 2020 | $2,051,000 | -31.4% | 127,972 | +2.2% | 0.00% | -20.0% |
Q4 2019 | $2,990,000 | +45.1% | 125,209 | +7.2% | 0.01% | +25.0% |
Q3 2019 | $2,061,000 | -26.4% | 116,829 | +6.8% | 0.00% | -20.0% |
Q2 2019 | $2,801,000 | -6.1% | 109,420 | +6.6% | 0.01% | -16.7% |
Q1 2019 | $2,983,000 | +121.3% | 102,612 | -0.1% | 0.01% | +100.0% |
Q4 2018 | $1,348,000 | -4.7% | 102,732 | +46.9% | 0.00% | 0.0% |
Q3 2018 | $1,414,000 | -20.0% | 69,919 | -6.5% | 0.00% | -25.0% |
Q2 2018 | $1,768,000 | +7.2% | 74,759 | +2.1% | 0.00% | +33.3% |
Q1 2018 | $1,649,000 | -29.1% | 73,219 | -1.8% | 0.00% | -40.0% |
Q4 2017 | $2,325,000 | -12.7% | 74,574 | -12.6% | 0.01% | -16.7% |
Q3 2017 | $2,664,000 | +112.8% | 85,372 | +17.0% | 0.01% | +100.0% |
Q2 2017 | $1,252,000 | -2.7% | 72,980 | -0.7% | 0.00% | 0.0% |
Q1 2017 | $1,287,000 | +37.1% | 73,482 | +3.6% | 0.00% | +50.0% |
Q4 2016 | $939,000 | -4.0% | 70,949 | +5.4% | 0.00% | -33.3% |
Q3 2016 | $978,000 | +46.8% | 67,341 | -0.3% | 0.00% | +50.0% |
Q2 2016 | $666,000 | -18.9% | 67,561 | +4.2% | 0.00% | -33.3% |
Q1 2016 | $821,000 | -30.2% | 64,816 | +0.0% | 0.00% | -25.0% |
Q4 2015 | $1,176,000 | +5.4% | 64,811 | +7.9% | 0.00% | 0.0% |
Q3 2015 | $1,116,000 | -21.8% | 60,076 | +2.8% | 0.00% | -20.0% |
Q2 2015 | $1,427,000 | +39.5% | 58,455 | +18.8% | 0.01% | +66.7% |
Q1 2015 | $1,023,000 | +56.7% | 49,205 | +16.5% | 0.00% | +50.0% |
Q4 2014 | $653,000 | +27.8% | 42,230 | +7.8% | 0.00% | 0.0% |
Q3 2014 | $511,000 | -28.9% | 39,170 | +8.9% | 0.00% | 0.0% |
Q2 2014 | $719,000 | +18.8% | 35,975 | +13.2% | 0.00% | 0.0% |
Q1 2014 | $605,000 | +7.3% | 31,782 | -4.2% | 0.00% | 0.0% |
Q4 2013 | $564,000 | +18.2% | 33,162 | +8.5% | 0.00% | +100.0% |
Q3 2013 | $477,000 | +56.9% | 30,562 | +20.2% | 0.00% | 0.0% |
Q2 2013 | $304,000 | – | 25,420 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |